由于心肌炎引起的急性心力衰竭在Takayasu的动脉炎中
M D L Castro de Oliveira Figueirôa1, M C Moura Costa2, P Rocha Lobo2
1BAHIANA - School of Medicine and Public Health, Salvador; Professor Edgard Santos University Hospital, Federal University of Bahia, Salvador.
Reumatismo
|September 24, 2024
概括
塔卡亚苏 (Takayasu) 是一个著名的武士.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 塔卡亚苏动脉炎 (TA) 是一种罕见的自身免疫性疾病,影响大动脉.
- 心血管并发症,包括心力衰竭,是TA患者死亡的重要原因.
- 肌心炎是高山氏动脉炎的一个未被认可的心脏表现.
研究的目的:
- 在Takayasu的动脉炎患者中报告严重急性心力衰竭的病例,这是心肌炎的次要原因.
- 突出免疫抑制疗法在治疗TA中心脏参与方面的有效性.
主要方法:
- 一个患有高山氏动脉炎的女性患者的病例报告.
- 详细介绍了临床表现,诊断工作和治疗过程.
- 对免疫抑制疗法的反应进行了监测.
主要成果:
- 患者出现了由于心肌炎引起的严重急性心力衰竭.
- 免疫抑制治疗导致显著的临床改善和心力衰竭症状的消失.
- 这个案例证明了有针对性的治疗带来了有利的结果.
结论:
- 肌心炎可能是高山氏动脉炎的关键表现.
- 早期诊断和及时的免疫抑制治疗对于管理TA中的心血管并发症至关重要.
- 这一案例强调了考虑TA患者心力衰竭的心脏参与的重要性.
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
Heart Failure Drugs: Inotropic Agents
539
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
539
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320


